Amazoniac
Member
- Role of hydrogen sulfide in duodenal HCO3(-) secretion
- Diet and relapsing ulcerative colitis: take off the meat?
- https://www.google.com/search?q=butyrogenic+fiber
"Mucosal application of H2S donor, NaHS, increases gastric and duodenal alkaline secretion in a concentration-dependent manner (Fig. 1). Interestingly, these reactions were markedly suppressed by the previous administration of the cyclooxygenase (COX) inhibitor indomethacin, suggesting that endogenous PGs may be involved in the increase in alkaline secretion by H2S. Endogenous PG is important for local regulation of alkaline secretion, and E-type PG (PGE2) has a strong alkaline secretagogue action. PGE2 has been shown to promote gastric and duodenal alkaline secretion via EP1 and EP3/EP4 receptors, respectively (5). In fact, the effects of NaHS are suppressed by selective EP3 and EP4 receptor antagonists, indicating that this response is mediated by endogenous PG. H2S has been reported to increase PGE2 production through induction of COX-2 in cardiomyocytes (9), and inhibition of H2S production in large intestine mucosa leads to decreased COX-2 expression and PGE2 synthesis (10). The authors have also confirmed that mucosal application of NaHS increases the PGE2 content of the duodenal mucosa. These findings suggest that H2S promotes duodenal alkaline secretion through increased mucosal PGE2 production."
"The promotion of duodenal alkaline secretion by topical application of NaHS is also significantly suppressed by the NO synthase (NOS) inhibitor NG-nitro-L-arginine methyl ester (L-NAME). This suggests that NO is involved in H2S-induced increase in alkaline secretion in addition to endogenous PG. H2S has been shown to promote NO production in the vascular endothelium (11), but similarly mucosal application of NaHS increases NO release into the duodenal lumen. The authors have previously reported that the NO donor, NOR3, promotes duodenal alkaline secretion via an increase in mucosal PGE2 (12). Since this reaction was suppressed by pretreatment with indomethacin, it is speculated that the promotion of alkaline secretion by NO is mediated by endogenous PG. Since the increase of alkaline secretion by NaHS is suppressed by indomethacin and L-NAME, it is considered that H2S increases NO release and PGE2 production, and as a result, promotes duodenal alkaline secretion."
"The promotion of duodenal alkaline secretion by topical application of NaHS is also significantly suppressed by the NO synthase (NOS) inhibitor NG-nitro-L-arginine methyl ester (L-NAME). This suggests that NO is involved in H2S-induced increase in alkaline secretion in addition to endogenous PG. H2S has been shown to promote NO production in the vascular endothelium (11), but similarly mucosal application of NaHS increases NO release into the duodenal lumen. The authors have previously reported that the NO donor, NOR3, promotes duodenal alkaline secretion via an increase in mucosal PGE2 (12). Since this reaction was suppressed by pretreatment with indomethacin, it is speculated that the promotion of alkaline secretion by NO is mediated by endogenous PG. Since the increase of alkaline secretion by NaHS is suppressed by indomethacin and L-NAME, it is considered that H2S increases NO release and PGE2 production, and as a result, promotes duodenal alkaline secretion."
- Diet and relapsing ulcerative colitis: take off the meat?
"It has been proposed that sulphide toxicity may be important in the pathogenesis of UC.[9,10] The initial evidence in this regard was demonstration that experimental exposure of colonic tissue to sulphide causes inhibition of butyrate use (see below), a defect similar to that observed in mucosal biopsies obtained from UC patients.[11] UC patients have significantly higher luminal concentrations of hydrogen sulphide than controls, and disease activity correlates with sulphide production rates.[12] Hydrogen sulphide induces hyperproliferation of colonic mucosa and this effect is antagonised by butyrate.[13] Treatment with 5-aminosalicylates and bismuth subsalicylates has been shown to reduce hydrogen sulphide production in the colonic lumen.[12,14] Apart from the direct toxicity of hydrogen sulphide, it has been speculated that thiols may react with sulfhydryl containing compounds to form persulfides, which may alter protein function as well as antigenicity, which could theoretical lead to a chronic immune mediated process, as known in UC.6"
"Patients with active extensive UC have decreased colonic butyrate oxidation. As remission of disease is associated with normalisation of butyrate oxidation, UC mucosa is not intrinsically altered in butyrate oxidation.[19]"
"So, how to increase faecal butyrate levels? In animal and human studies, ingestion of resistant fibre has resulted in an increase in the population of Bifidobacillus and Lactobacillus in the colon and an increase in faecal butyrate concentrations. Administration of oat bran over three months to UC patients in remission (corresponding to 20 g dietary fibre) has recently been shown to result in increased faecal butyrate levels and in this pilot study no relapses were observed.[22] Alternative strategies of delivering short chain fatty acids to the inflamed colon are by providing a substrate, a “prebiotic”, for short chain fatty acid production by colonic bacteria, or directly delivering probiotics to the intestinal lumen." "Butyrate enemas have been shown to be of benefit in the management of distal UC.[20,21]"
"Patients with active extensive UC have decreased colonic butyrate oxidation. As remission of disease is associated with normalisation of butyrate oxidation, UC mucosa is not intrinsically altered in butyrate oxidation.[19]"
"So, how to increase faecal butyrate levels? In animal and human studies, ingestion of resistant fibre has resulted in an increase in the population of Bifidobacillus and Lactobacillus in the colon and an increase in faecal butyrate concentrations. Administration of oat bran over three months to UC patients in remission (corresponding to 20 g dietary fibre) has recently been shown to result in increased faecal butyrate levels and in this pilot study no relapses were observed.[22] Alternative strategies of delivering short chain fatty acids to the inflamed colon are by providing a substrate, a “prebiotic”, for short chain fatty acid production by colonic bacteria, or directly delivering probiotics to the intestinal lumen." "Butyrate enemas have been shown to be of benefit in the management of distal UC.[20,21]"
- https://www.google.com/search?q=butyrogenic+fiber